Clinical Trial Update: SMART China, A Multi-center Clinical Registry Study [Phase 4]

View source ↗

Summary

This Phase 4 clinical registry update (SMART China) reports completion and posting of results for a multi-center study evaluating Biosense Webster devices in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED | Results posted: 2018-07-31